Marcum Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.97M | Sell |
9,409
-30
| -0.3% | -$6.29K | 0.17% | 65 |
|
|
2024
Q4 | $1.68M | Sell |
9,439
-313
| -3% | -$55.6K | 0.15% | 73 |
|
|
2024
Q3 | $1.93M | Sell |
9,752
-353
| -3% | -$69.7K | 0.18% | 61 |
|
|
2024
Q2 | $1.73M | Buy |
10,105
+31
| +0.3% | +$5.32K | 0.17% | 61 |
|
|
2024
Q1 | $1.83M | Sell |
10,074
-616
| -6% | -$112K | 0.19% | 57 |
|
|
2023
Q4 | $1.66M | Buy |
10,690
+205
| +2% | +$31.8K | 0.18% | 62 |
|
|
2023
Q3 | $1.56M | Sell |
10,485
-478
| -4% | -$71.2K | 0.19% | 63 |
|
|
2023
Q2 | $1.48M | Buy |
10,963
+436
| +4% | +$58.7K | 0.17% | 64 |
|
|
2023
Q1 | $1.68M | Buy |
10,527
+29
| +0.3% | +$4.62K | 0.21% | 54 |
|
|
2022
Q4 | $1.7M | Sell |
10,498
-81
| -0.8% | -$13.1K | 0.23% | 51 |
|
|
2022
Q3 | $1.42M | Buy |
10,579
+51
| +0.5% | +$6.85K | 0.22% | 58 |
|
|
2022
Q2 | $1.61M | Buy |
10,528
+376
| +4% | +$57.6K | 0.24% | 51 |
|
|
2022
Q1 | $1.65M | Sell |
10,152
-1,022
| -9% | -$166K | 0.23% | 60 |
|
|
2021
Q4 | $1.51M | Buy |
11,174
+34
| +0.3% | +$4.6K | 0.21% | 68 |
|
|
2021
Q3 | $1.2M | Buy |
11,140
+747
| +7% | +$80.6K | 0.19% | 78 |
|
|
2021
Q2 | $1.17M | Buy |
10,393
+45
| +0.4% | +$5.07K | 0.19% | 75 |
|
|
2021
Q1 | $1.12M | Buy |
10,348
+7,140
| +223% | +$773K | 0.18% | 74 |
|
|
2020
Q4 | $344K | Buy |
3,208
+803
| +33% | +$86.1K | 0.08% | 91 |
|
|
2020
Q3 | $211K | Sell |
2,405
-39
| -2% | -$3.42K | 0.06% | 107 |
|
|
2020
Q2 | $240K | Buy |
+2,444
| New | +$240K | 0.07% | 96 |
|